OPRX News and Press, OptimizeRx Corporation From 04/23/25

WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conferen...

WALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that, as ...

2025-03-12 11:04:09 ET OptimizeRx Corporation (OPRX) Q4 2024 Results Conference Call March 12, 2025 08:30 AM ET Company Participants Steve Silvestro - President Edward Stelmakh - Chief Financial Officer and Chief Operational Officer Andrew D'Silva - Senior Vice P...

2025-03-12 07:32:26 ET More on OptimizeRx OptimizeRx confirms receipt of notice of director nominations OptimizeRX edges higher as holder pushes firm to explore a sale Seeking Alpha’s Quant Rating on OptimizeRx Historical earnings data for OptimizeRx ...

Q4 revenue of $32.3 million, increasing 14% year-over-year Q4 gross profit increased 23% year-over-year to $22.0 million with gross margin of 68% Company generated revenue from 48 DAAP deals in 2024, up from 24 in 2023 WALTHAM, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- OptimizeR...

Portage Biotech Inc. (PRTG) is expected to report for Q3 2025 Aimei Health Technology Co. Ltd (AFJK) is expected to report for quarter end 2024-12-31 Generation Bio Co. (GBIO) is expected to report $-0.28 for Q4 2024 TAT Technologies Ltd. (TATT) is expected to report for quarter end 2...

2025-03-11 08:08:01 ET More on OptimizeRx OptimizeRX edges higher as holder pushes firm to explore a sale Seeking Alpha’s Quant Rating on OptimizeRx Historical earnings data for OptimizeRx Financial information for OptimizeRx Read the full ar...

WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today confirmed that it h...

2025-03-10 07:40:22 ET More on OptimizeRx OptimizeRX edges higher as holder pushes firm to explore a sale Seeking Alpha’s Quant Rating on OptimizeRx Historical earnings data for OptimizeRx Financial information for OptimizeRx Read the full ar...

WALTHAM, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced it has ap...